XML 319 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity Method Investments - Textual (Details)
$ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2021
AUD ($)
Schedule of Equity Method Investments [Line Items]        
Cash receipts from Middlemount $ (500,000) $ (23,200,000) $ (27,300,000)  
Net income (loss) 371,400,000 (1,873,800,000) (185,100,000)  
Changes in tax reserves 1,900,000 (7,700,000) 3,000,000.0  
Revenues 3,318,300,000 2,881,100,000 4,623,400,000  
Equity method investment, current assets 1,801,700,000 1,420,300,000    
Equity method investment, current liabilities 931,700,000 790,600,000    
Insurance recovery 0 0 125,000,000.0  
Equity method investment and financing receivables related to Middlemount        
Schedule of Equity Method Investments [Line Items]        
Insurance recovery $ 12,500,000      
Performance Units        
Schedule of Equity Method Investments [Line Items]        
Stock price measurement period 3 years      
Return on invested capital period 3 years      
Equity method investment and financing receivables related to Middlemount        
Schedule of Equity Method Investments [Line Items]        
Cash receipts from Middlemount $ 43,500,000 0 14,700,000  
Equity interest percentage of revolving loans limit 50.00%     50.00%
Revolving loan limit       $ 50
Financing receivable, stated interest rate (in percent) 10.00%      
Intercompany loans, carrying value   46,200,000    
Equity method investment and financing receivables related to Middlemount        
Schedule of Equity Method Investments [Line Items]        
Net income (loss)     17,000,000  
Valuation allowance $ 33,000,000 33,000,000    
Revenues 265,000,000 123,000,000 $ 160,000,000  
Equity method investment, current assets 83,100,000 31,000,000    
Equity method investment ,noncurrent assets $ 269,900,000 301,800,000    
Ownership percentage of equity method investment 50.00%     50.00%
Equity method investment, current liabilities $ 254,900,000 273,800,000    
Equity method investment, noncurrent liabilities $ 79,500,000 $ 83,500,000